Christopher M. Holman
Impact in
-
- Intellectual Property and Patents
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Intellectual Property and Patents 38
- Physiology 32
- Biomedical Ethics and Regulation 32
- Co-authors
- Harold E. Van Wart (3 shared papers)William F. Benisek (2 shared papers)Michelle F. Browner (2 shared papers)Michael R. Gehring (2 shared papers)Chen‐Chen Kan (2 shared papers)Anthony Welch (2 shared papers)Mitchell C. Brenner (1 shared paper)Martin Huber (1 shared paper)
- Journals
- Biochemistry (4 papers)Nature Biotechnology (2 papers)Indiana Law Review (1 paper)Archives of Biochemistry and Biophysics (1 paper)Science (1 paper)
- Partner nations
- United StatesSingaporeCanada
In The Last Decade
Christopher M. Holman
68 papers receiving 283 citations
Peers
Comparison fields: 5 of 86
- Management of Technology and Innovation 80
- Cancer Research 67
- Business and International Management 7
- Oncology 58
- Molecular Biology 123
Countries citing papers authored by Christopher M. Holman
This map shows the geographic impact of Christopher M. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Holman more than expected).
Fields of papers citing papers by Christopher M. Holman
This network shows the impact of papers produced by Christopher M. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Holman. The network helps show where Christopher M. Holman may publish in the future.
Co-authors
The 19 scholars most cited alongside Christopher M. Holman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 42 | |
| 2 | 1995 | 32 | |
| 3 | 1998 | 28 | |
| 4 | 1994 | 22 | |
| 5 | 2012 | 20 | |
| 6 | The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation | 2008 | 19 |
| 7 | 2008 | 15 | |
| 8 | 1995 | 11 | |
| 9 | 2015 | 9 | |
| 10 | 2019 | 7 | |
| 11 | Biotechnology's Prescription for Patent Reform | 2006 | 5 |
| 12 | 2018 | 5 | |
| 13 | 1989 | 4 | |
| 14 | 2012 | 4 | |
| 15 | 2010 | 4 | |
| 16 | 2011 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2012 | 4 | |
| 19 | 2015 | 3 | |
| 20 | 2018 | 3 |
About Christopher M. Holman
Christopher M. Holman is a scholar working on Management of Technology and Innovation, Physiology, Artificial Intelligence, Molecular Biology and Sociology and Political Science, having authored 101 papers that have together received 317 indexed citations. Recurring topics across this work include Intellectual Property and Patents (38 papers), Biomedical Ethics and Regulation (32 papers), Law, AI, and Intellectual Property (22 papers), Pharmaceutical Economics and Policy (13 papers), CRISPR and Genetic Engineering (12 papers), Genetically Modified Organisms Research (9 papers), Biotechnology and Related Fields (8 papers) and Legal Systems and Judicial Processes (5 papers). The work is most often cited by research in Management of Technology and Innovation (80 citations), Cancer Research (67 citations), Business and International Management (7 citations), Oncology (58 citations) and Molecular Biology (123 citations). Christopher M. Holman has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Harold E. Van Wart, William F. Benisek, Michelle F. Browner, Michael R. Gehring, Chen‐Chen Kan, Anthony Welch, Mitchell C. Brenner, Martin Huber, Andrew W. Torrance and Joshua D. Sarnoff. Their work appears in journals such as Biochemistry, Nature Biotechnology, Indiana Law Review, Archives of Biochemistry and Biophysics and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.